3
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Dermatologic
1
Classical hematology
1
Conditions
Myelodysplastic Syndromes
361
Leukemia, Myeloid, Acute
302
Myeloproliferative Disorders
155
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
142
Precursor Cell Lymphoblastic Leukemia-Lymphoma
115
Primary Myelofibrosis
103
Leukemia, Myelomonocytic, Chronic
89
Lymphoma, Non-Hodgkin
76
Leukemia
71
Polycythemia Vera
64
Multiple Myeloma
55
Hodgkin Disease
50
Hematologic Neoplasms
49
Leukemia, Lymphocytic, Chronic, B-Cell
44
Leukemia, Biphenotypic, Acute
41
Thrombocythemia, Essential
40
Lymphoma
40
Myelodysplastic-Myeloproliferative Diseases
32
Neoplasms
29
Leukemia, Myeloid, Chronic-Phase
28
Anemia, Refractory, with Excess of Blasts
24
Recurrence
23
Anemia, Aplastic
21
Lymphoma, Mantle-Cell
20
Lymphoma, Follicular
20
Hematologic Diseases
20
Burkitt Lymphoma
20
Blastic Plasmacytoid Dendritic Cell Neoplasm
20
Blast Crisis
20
Histiocytosis, Langerhans-Cell
19
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lupus Erythematosus, Systemic
×
Myeloid
×
1 year
×
Clear all
NCT02450396
2026-03-27
EGR2
Assistance Publique - Hôpitaux de Paris
Withdrawn